Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

First Page		Document Content
Date: 2015-11-04 13:26:51		Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr Add to Reading List Source URL: posters.omed.s3.amazonaws.com Download Document from Source Website File Size: 526,29 KB Share Document on Facebook